BNIP3 as a Progression Marker in Primary Human Breast Cancer; Opposing Functions inIn situVersus Invasive Cancer

Ern Yu Tan, Leticia Campo, Cheng Han, Helen Turley, Francesco Pezzella, Kevin C. Gatter, Adrian L. Harris, Stephen B. Fox
2007 Clinical Cancer Research  
Purpose: BNIP3 is involved in cell death and cell survival via autophagy. Its perinecrotic localization within ductal carcinoma in situ (DCIS) suggests an involvement in neoplastic cellular adaptation to low oxygen tension. This study has investigated the role of BNIP3 in normal and neoplastic breast. Experimental Design:Whole sections from11normal breast and microarrayed tissue cores from 81 DCIS and 251 invasive carcinomas were stained for BNIP3 and hypoxia-inducible factor-1a. The pattern
more » ... level of BNIP3 expression were correlated with clinicopathologic variables and hypoxia-inducible factor-1a. Results: BNIP3 expression was significantly up-regulated in the cytoplasm of DCIS and invasive carcinoma compared with normal breast (P = 0.0005 and P < 0.0001, respectively). Nuclear
doi:10.1158/1078-0432.ccr-06-1466 pmid:17255267 fatcat:6bx42ntpt5h3foufavffjcp5bu